Completed PHASE4 INTERVENTIONAL 2-arm NCT00780793

Spacing of TNF-blocker Injections in Rheumatoid Arthritis Study (STRASS)

Effect of TNF-blocker Injections Spacing on Rheumatoid Arthritis Inflammatory Activity in Patients in Clinical Remission or Low Disease Activity

Sponsor: Assistance Publique - Hôpitaux de Paris

Conditions Rheumatoid Arthritis

Interventions DMARD maintenance progressive spacing of TNF-blocker injections

Updated 5 times since 2017 Last updated: Feb 1, 2012 Started: Sep 30, 2008 Primary completion: Sep 30, 2011 Completion: Sep 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Rheumatoid Arthritis, this trial is completed. The trial is conducted by Assistance Publique - Hôpitaux de Paris and has accumulated 5 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Sep 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Assistance Publique - Hôpitaux de Paris
French Society of Rheumatology

Data source: Assistance Publique - Hôpitaux de Paris

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Paris, France